Micafungin
- TRADE NAME: Mycamine (Astellas)
- INDICATIONS: Invasive candidiasis, esophageal candidiasis
- CLASS: Antifungal / antimycotic, Antimicrobial, Antimycobacterial; echinocandin
- HALF-LIFE: 11–21 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amphotericin B, Conivaptan, Cyclosporine, Itraconazole, Nifedipine, Sirolimus
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 02/16/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric